CD8A and neoplasm: To validate the previous finding suggesting a lower frequency of tumor-reactive CD8 TIL in HR+ breast cancer patients with lymph node metastasis, we analyzed two independent single-cell RNA sequencing (scRNA-seq) datasets of breast tumors.23